Pronunciation:
kro-fel-e-mer
Trade Name(s)
Ther. Class.
antidiarrheals
Pharm. Class.
catechins
Symptomatic relief of non-infectious diarrhea in HIV-infected patients currently receiving antiretroviral therapy.
Therapeutic Effect(s):
Decreased incidence and severity of diarrhea.
Absorption: Minimal absorption following oral administration.
Distribution: Unknown.
Metabolism and Excretion: Unknown.
Half-life: Unknown.
TIME/ACTION PROFILE
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | unknown | unknown | unknown |
Contraindicated in:
Use Cautiously in:
CNS: anxiety
EENT: nasopharyngitis
GI: abdominal distention, flatulence, hemorrhoids, nausea, ↑ liver function tests
GU: urinary tract infection
MS: arthralgia, back pain, musculoskeletal pain
Resp: bronchitis, cough, upper respiratory tract infection
* CAPITALS indicate life-threatening.
Underline indicate most frequent.
Drug-Drug
Due to minimal systemic absorption, interactions are unlikely.
PO (Adults): 125 mg twice daily.
Delayed-release tablets: 125 mg
Decreased incidence and severity of diarrhea.
To view other topics, please log in or purchase a subscription.
Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Complete Product Information.